[Evaluation of the immune infiltrate in breast cancer].

This article reviews elements of the immune response to cancer, methods of TIL analysis, evidence of TIL' prognostic and predictive value in the current breast cancer management as well as the perspectives for use of TIL' characteristics as biomarkers in breast cancer immunotherapy. PMID: 27986267 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/27986267?dopt=Abstract

Source: Bulletin du Cancer - December 12, 2016 Category: Cancer & Oncology Authors: Radosevic-Robin N, Béguinot M, Penault-Llorca F Tags: Bull Cancer Source Type: research